Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Lin

Showing results (141-150 of 163) with videos related to

Pageof 17
Sort By:
Cancer Research|November 21, 2023
Topoisomerase 1 Inhibition in MYC-Driven Cancer Promotes Aberrant R-Loop Accumulation to Induce Synthetic LethalityPeter Lin, Corey Lourenco, Jennifer Cruickshank, et al.
Journal of Vascular Surgery|March 13, 2018
Gore Iliac Branch Endoprosthesis for treatment of bilateral common iliac artery aneurysmsThomas S Maldonado, Nilo J Mosquera, Peter Lin, et al.
Lung|February 22, 2023
Canadian Health Care Professionals' Familiarity with Chronic Cough Guidelines and Experiences with Diagnosis and Management: A Cross-Sectional SurveyElena Kum, Danica Brister, Nermin Diab, et al.
Haematologica|December 31, 2011
Chronic phase chronic myeloid leukemia patients with low OCT-1 activity randomized to high-dose imatinib achieve better responses and have lower failure rates than those randomized to standard-dose imatinibDeborah L White, Jerald Radich, Simona Soverini, et al.
Bioorganic & Medicinal Chemistry|February 6, 2008
Fused bicyclic pyrrolizinones as new scaffolds for human NK1 antagonistsGregori J Morriello, Robert J Devita, Sander G Mills, et al.
Canadian Journal of Diabetes|September 28, 2013
Type 2 diabetes mellitus management in Canada: is it improving?Lawrence A Leiter, Lori Berard, C Keith Bowering, et al.
JAMA Network Open|October 30, 2020
Evaluation of Concordance Between Original Death Certifications and an Expert Panel Process in the Determination of Sudden Unexplained Death in ChildhoodLaura Gould Crandall, Joyce H Lee, Daniel Friedman, et al.
Bioorganic & Medicinal Chemistry Letters|August 22, 2006
4-Aminoquinoline melanin-concentrating hormone 1-receptor (MCH1R) antagonistsJinlong Jiang, Peter Lin, Myle Hoang, et al.
Bioorganic & Medicinal Chemistry Letters|July 20, 2007
The discovery of potent, selective, and orally bioavailable hNK1 antagonists derived from pyrrolidinePeter Lin, Lehua Chang, Robert J Devita, et al.
Bioorganic & Medicinal Chemistry Letters|August 22, 2006
2-Aminoquinoline melanin-concentrating hormone (MCH)1R antagonistsJinlong Jiang, Myle Hoang, Jonathan R Young, et al.
Pageof 17

Showing results (141-150 of 163) with videos related to

Sort By:
Pageof 17
Cancer Research|November 21, 2023
Topoisomerase 1 Inhibition in MYC-Driven Cancer Promotes Aberrant R-Loop Accumulation to Induce Synthetic LethalityPeter Lin, Corey Lourenco, Jennifer Cruickshank, et al.
Journal of Vascular Surgery|March 13, 2018
Gore Iliac Branch Endoprosthesis for treatment of bilateral common iliac artery aneurysmsThomas S Maldonado, Nilo J Mosquera, Peter Lin, et al.
Lung|February 22, 2023
Canadian Health Care Professionals' Familiarity with Chronic Cough Guidelines and Experiences with Diagnosis and Management: A Cross-Sectional SurveyElena Kum, Danica Brister, Nermin Diab, et al.
Haematologica|December 31, 2011
Chronic phase chronic myeloid leukemia patients with low OCT-1 activity randomized to high-dose imatinib achieve better responses and have lower failure rates than those randomized to standard-dose imatinibDeborah L White, Jerald Radich, Simona Soverini, et al.
Bioorganic & Medicinal Chemistry|February 6, 2008
Fused bicyclic pyrrolizinones as new scaffolds for human NK1 antagonistsGregori J Morriello, Robert J Devita, Sander G Mills, et al.
Canadian Journal of Diabetes|September 28, 2013
Type 2 diabetes mellitus management in Canada: is it improving?Lawrence A Leiter, Lori Berard, C Keith Bowering, et al.
JAMA Network Open|October 30, 2020
Evaluation of Concordance Between Original Death Certifications and an Expert Panel Process in the Determination of Sudden Unexplained Death in ChildhoodLaura Gould Crandall, Joyce H Lee, Daniel Friedman, et al.
Bioorganic & Medicinal Chemistry Letters|August 22, 2006
4-Aminoquinoline melanin-concentrating hormone 1-receptor (MCH1R) antagonistsJinlong Jiang, Peter Lin, Myle Hoang, et al.
Bioorganic & Medicinal Chemistry Letters|July 20, 2007
The discovery of potent, selective, and orally bioavailable hNK1 antagonists derived from pyrrolidinePeter Lin, Lehua Chang, Robert J Devita, et al.
Bioorganic & Medicinal Chemistry Letters|August 22, 2006
2-Aminoquinoline melanin-concentrating hormone (MCH)1R antagonistsJinlong Jiang, Myle Hoang, Jonathan R Young, et al.
Pageof 17